RecruitingPhase 1NCT05018819
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CP
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Cerebral Palsy
Sponsor
The Foundation for Orthopaedics and Regenerative Medicine
Enrollment
15 participants
Start Date
Feb 1, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Cerebral Palsy
Eligibility
Inclusion Criteria1
- Diagnosis of Cerebral Palsy
Exclusion Criteria9
- Active infection
- Active cancer
- Chronic multisystem organ failure
- Pregnancy
- Clinically significant Abnormalities on pre-treatment laboratory evaluation
- Medical condition that would (based on the opinion of the investigator) compromise patient's safety
- Previous organ transplant
- Seizure disorder
- Hypersensitivity to sulfur
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BIOLOGICALAlloRx
cultured allogeneic adult umbilical cord derived mesenchymal stem cells
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05018819
Related Trials
Investigating New Methods to Study Movement in Children and Young Adults With Movement Disorders.
NCT064985961 location
Spinal Cord Stimulation for Children With Cerebral Palsy
NCT075160671 location
Cerebral Palsy and the Study of Brain Activity During Motor Tasks
NCT018297241 location
Healing Tiny Minds: Rural Recovery Through Virtual and Lived Experience Care
NCT066435981 location
Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performance of Children With Cerebral Palsy
NCT074327891 location